28 Articles

Evidence-based coverage of weight loss drugs, GLP-1 science, metabolic health, and fat loss strategies. Includes the latest research on Ozempic, Mounjaro, Wegovy, tirzepatide, and semaglutide — reviewed by Dr. Ajit Kumar, MD (Medicine) | MA Psychology.

Ozempic Now Comes in a Pill – Everything You Need to Know

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an oral version […]

Mounjaro vs Ozempic: Which One Destroys More Muscle? (New Research)

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: significant muscle […]

Survodutide: The New Weight Loss Drug That Could Beat Ozempic and Zepbound

Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced weight loss […]

Get free weekly health insights

Join thousands of readers. No spam. Unsubscribe anytime.

Prefer a one-time download? Get our free Weight Management guide →

About UsContact UsMedical DisclaimerEditorial PolicyAffiliate DisclosureTerms & ConditionsCookie PolicyDisclaimerPrivacy Policy